Cell-Wall Alterations as an Attribute of Mycobacterium tuberculosis in Latent Infection

Journal of Infectious Diseases

Volumn 188, Issue 9, 2003, Pages 1326-1331

  Seiler, Peter ^a   Ulrichs, Timo ^a   Bandermann, Silke ^a   Pradl, Lydia ^a   Jörg, Sabine ^a   Krenn, Veit ^b   Morawietz, Lars ^b   Kaufmann, Stefan H E ^a,d   Aichele, Peter ^a,c  

^a MAX PLANCK INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; POLYCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; BACTERIUM DETECTION; CELL COMPOSITION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EXPERIMENTAL INFECTION; HUMAN; HUMAN TISSUE; LUNG PARENCHYMA; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; STAINING;

ANIMALS; BACTERIAL PROTEINS; BCG VACCINE; CELL WALL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; ROSANILINE DYES; STAINING AND LABELING; TUBERCULOSIS;

EID: 0242552007     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/378563     Document Type: Article

References (18)

1. Nolte FS, Metchock B. Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6ht ed. Washington DC: American Society for Microbiology Press, 1995:400-37.
2. Bishop PJ, Neumann G. The history of the Ziehl-Neelsen stain. Tubercle 1970; 51:196-206.
3. Wiley EL, Mulhollan TJ, Beck B, Tyndall JA, Freeman RG. Polyclonal antibodies raised against bacillus Calmette-Guerin, Mycobacterium duvalii, and Mycobacterium paratuberculosis used to detect mycobacteria in tissue with the use of immunohistochemical techniques. Am J Clin Pathol 1990; 94:307-12.
4. Ulrichs T, Kaufmann SH. Mycobacterial persistence and immunity. Front Biosci 2002; 7:d458-69.
5. Wayne LG, Sohaskey CD. Nonreplicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol 2001; 55:139-63.
6. Orme IM. The latent tuberculosis bacillus (I'll let you know if I ever meet one). Int J Tuberc Lung Dis 2001; 5:589-93.
7. Khomenko AG. The variability of Mycobacterium tuberculosis in patients with cavitary pulmonary tuberculosis in the course of chemotherapy. Tubercle 2002; 68:243-53.
8. Canetti G. The tubercle bacillus. New York: Springer Publishing, 1955: 1-55.
9. Csillag A. The mycococcus form of mycobacteria. J Gen Microbiol 1964; 34:341-52.
10. Much H. Über die granuläre, nach Ziehl nicht färbbare Form des Tuberkulosevirus. Beitr Klin Tuberk 1907; 8:85-99.
11. Much H. Die nach Ziehl nicht darstellbaren Formen des Tuberkelbacillus. Berl Klin Wochenschr 1908; 45:691-4.
12. Behr MA, Warren SA, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353:444-9.
13. Bocart D, Lecossier D, De Lassence A, Valeyre D, Battesti JP, Hance AJ. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis 1992; 145:1142-8.
14. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992; 339:1012-5.
15. Mitchison DA. Basic mechanisms of chemotherapy. Chest 1979; 76: 771-81.
16. McKinney JD. In vivo veritas: the search for TB drug targets goes live. Nat Med 2000; 6:1330-3.
17. Collins HL, Kaufmann SH. Prospects for better tuberculosis vaccines. Lancet Infect Dis 2001; 1:21-8.
18. Kaufmann SH. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 2001; 1:20-30.